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Purpose: There are many approaches have been developed to manage and
treat articular cartilage injuries. For example, bone marrow stimulating
techniques, mosaicplasty and autologous chondrocyte implantation.
However, current clinical therapies still have some limitations regarding to
the formation of ﬁbrocartilage. On the other hand, tissue engineering of
cartilage has been recognized as a new treatment for cartilage damage, but
it still has some issues need to be veriﬁed. In this study, wewanted to create
an articular mimetic environment for better hyaline cartilage formation.
Therefore, the components of the articular such as cartilage fragments and
synovialmembraneswere added and the effects on chondrogenesis of bone
marrow-derived mesenchymal stem cells (BM-MSCs) which were used for
cartilage tissue engineering were investigated (schemed as ﬁgure 1).
Methods: Cartilage fragments, synovial membranes and BM-MSCs were
tested along or in different combinations (as table 1) for chondrogenesis.
The components of different groups were wrapped by type I collagen gel
and treated with induction medium. The matrix were analyzed at 0, 14,
and 28 days after induction. Scanning electronic microscopy and histo-
logical staining by H&E and alcian blue were employed. Glycosaminogly-
cans (GAGs) content were measured and gene expression of Col I, Col II, Col
X, SOX9, and aggrecan of matrix were analyzed as well.
Results: Type II collagen gene expression of groups containing cartilage
fragments were increased. When BM-MSCs were co-cultured with carti-
lage fragments and synovial membranes, histological and GAGs analysis
showed that GAGs secretion from BM-MSCs was increased and the
proliferation of BM-MSCs which closed to cartilage fragments was
promoted. Finally, aggrecan and type II collagen expression of BM-MSCs
were also increased while chondrocyte hypertrophy was inhibited after
incubation for 2 weeks.
Conclusions:We demonstrated that the articular cartilage fragments and
synovial membranes in combination could promote chondrogenic differ-
entiation of BM-MSCs. We hope these preliminary results could help
develop an optimal condition for hyaline cartilage repair and be able to be
applied along with bone marrow stimulating techniques in clinical treat-
ment in the future.Experiment groups
Group Cartilage fragments Synovial membranes BM-MSCs
1 + - -
2 - + -
3 + + -
4 - - +
5 + - +
6 - + +
7 + + +Ă544
ROLE OF POLYAMINES IN CHONDROGENESIS OF ADIPOSE DERIVED
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Purpose: Adipose derived stem cells (ASC) are an attractive cell source for
regenerative purposes in orthopedics, because of their accessibility and
high differentiation potential, upon delivery of appropriate stimuli which
mimick the organogenetic natural microenvironment.
Polyamines are naturally occurring, positively charged polycations able to
interact with negatively charged compounds and structures within the
living cell thus controlling several cellular processes including cell differ-
entiation and already implicated in bone growth and development. Hence,
we investigated the effects of exogenously added spermine in chondro-
genesis of ASC recapitulated in 3D micromass cultures, to tease out the
effects on gene and protein expression of key chondrogenesis regulatory
transcription factors, markers and effectors.
Methods: Adipose tissue was obtained from the surgical subcutaneous
area of 20 OA patients (age 29-72) undergoing hip arthroplasty. ASC were
obtained from the stromal vascular fraction with conventional procedures
and used within p2-p3 passage. To monitor phenotypic homogeneity, ﬂow
cytometric analysis of the cells at p1 passage was carried out to evaluate
the expression of CD 31, 34, 45, 271, 44, 73, 90 and 105. Micromasses were
seeded in control (D-MEM 10% FCS and 50 mg/ml ascorbic acid) or chon-
drogenic medium, with or without the addition of 5 mM spermine to
evaluate its chondrogenic ability across 1, 2 and 3 weeks chondrogenic
maturation. Osteogenic medium was used as control. We evaluated the
effects of spermine addition on molecular markers of chondrocyte differ-
entiation at the level of gene (real time PCR) and protein (western blot and
immunohistochemistry) expression as well as the effects on extracellular
matrix deposition and mineralization.
Results: The number of ASC per unit (g) of adipose tissue was inversely
correlated with the age of both male and female subjects and positively
correlated with the body mass index. ASC samples were highly positive for
CD44, CD73 and CD90, being the expression of the latter inversely corre-
lated with the age of the subjects. In micromasses, spermine was able to
increase the gene expression of Sox-9 and Runx-2 which was particularly
consistent at 2 weeks in chondrogenic medium, and alkaline phosphatase
which was increased upon spermine addition already at early time points
both in control and chondrogenic medium. Western blot conﬁrmed an
increased Runx-2 expression upon spermine addition. Mineralization
evaluated in micromass lysates indicated an increased calcium content
upon spermine addition particularly at 2 weeks in chondrogenic medium.
Conclusions: Polyamine can represent a potential tool to improve the
differentiation of ASC for bone tissue engineering via recapitulation of
endochondral ossiﬁcation.
Acknowledgement: This work was supported by FIRB (MIUR, Italy) and
Fondi cinque per mille (Ministero della Salute, Italy). The authors wish to
thank Prof C. Ventura for helpful discussion during the early phase of the
work.545
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Ribelles 3, F. Prósper 3, I. Izal 1. 1Univ. of Navarra, Pamplona, Spain; 2Univ.
Clinic of Navarra, Pamplona, Spain; 3Univ. of Valencia, Valencia, Spain
Purpose: Cartilage injuries are poorly repaired after surgery, since carti-
lage is a tissue with a very limited capacity to regenerate. Apart from other
Abstracts / Osteoarthritis and Cartilage 20 (2012) S54–S296 S275surgical attempts, autologous chondrocyte implantation (ACI) was the ﬁrst
cell therapy approach developed for these kinds of lesions. Chondrocyte
usage nevertheless is limited by the dedifferentiation occurred when
expanded in monolayer. Bone marrow-derived Mesenchymal Stem Cells
(MSC) emerge as ideal cells to be implanted in the site of cartilage lesions.
Methods: Here we use MSC to treat sheep cartilage lesions implanted in
the upper cartilage layer of bilayered PLLA scaffolds, which hold a lower
layer enriched with Hydroxiapatite to facilitate osteointegration of the
scaffold.
Results: After evolutions of 1.5, 3 and 6 months, lesions showed a slight
but non signiﬁcant decrease in the mankin score for cartilage found in the
lesioned area (in animals treated with unloaded and cell loaded scaffolds)
suggesting a progressive degradation of the tissue. Nevertheless, staining
with Safranine-O showed the presence of more cartilaginous tissue in
animals evolve for 6 months with MSC loaded scaffolds, demonstrating
a more regeneration of the tissue when MSC were implanted in cartilage
lesions. Unfortunately new formed tissue did not appear in the cartilage
layer, but inside the hole performed during surgery, which might suggest
some incapacity of the scaffold to support the presence of cells aligned
with the surface in order to integrate tissue to the surrounding cartilage.
Finally, collagen type II and aggrecanwere found in the regenerated tissue.
Conclusions: The use of MSCs is a promising alternative for the treatment
of cartilage damage, but administration in the core of scaffolds needs to be
improved.
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MESENCHYMAL STEM CELL THERAPY IN A RAT MODEL OF
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Purpose: Mesenchymal stem cells (MSCs) are promising candidates for
cartilage regeneration and osteoarthritis (OA) therapies, due to their ability
to form cartilage and to secrete immunomodulatory factors. Since OA
comprises many different processes, we evaluated the effects of intra-
articularly injected cultured MSCs on multiple aspects of OA pathology,
including pain, cartilage degeneration and subchondral bone changes, in
a rat model in vivo. In order to explore potential options to enhance clinical
translatability, we studied rat- and human cultured MSCs, as well as
freshly isolated rat bone marrow mononuclear cells (BMMNCs).
Methods: Osteoarthritis was induced unilaterally in 32 male wistar rats
(16 weeks old) by intra-articular injection with 300 mg mono-iodoacetate
(MIA). Three weeks after OA induction rats were randomly divided into
four treatment groups: 1. Control (saline); 2. Rat MSCs; 3. Rat BMMNCs and
4. HumanMSCs. Rat MSCs and humanMSCs were given at a dose of 1 x 106
cells in 50ul saline per joint, rat BMMNCs were given at a dose of 10 x 106.
Rats where euthanized four weeks after treatment injections. Before and
after OA induction, as well as 4 weeks after treatment, hind limb weight
distribution between the osteoarthritic and the contralateral healthy joint
was used as an index of joint discomfort. Ex vivo uCT analysis was per-
fomed to assess changes in the subchondral bone plate and histology was
used to evaluate loss of glycosaminoglycans and development of structural
damage in the cartilage at the endpoint of the study. Statistical analysis
was performed with repeated measures ANOVA and paired t-tests for hind
limb weight distribution, with one way ANOVA and unpaired t-tests for
mCT data, and with non-parametric Kruskal-Wallis and Mann-Whitney-
tests for histology scores. For all tests, p values <0.05 were considered
statistically signiﬁcant.
Results: Hind limb weight distribution (Figure 1): After MIA injection,
signiﬁcantly less weight was distributed to the affected leg compared to
baseline (P < 0.001), indicating pain sensation. The rats treated with rat
MSCs distributed signiﬁcantly more weight to their affected paw 4 weeks
after treatment than before treatment (P ¼ 0.003), whereas none of the
other groups showed a signiﬁcant change in weight distribution. The
groups however, did not differ statistically signiﬁcant at the endpoint of
the study.
Subchondral bone changes: MIA injected knees had a signiﬁcantly more
porous (P < 0.001) and thinner (P ¼ 0.005) subchondral plate than controlknees. Rats treated with rat MSCs or rat BMMNCs showed the least sub-
chondral bone changes, although no statistically signiﬁcant differences
between treatment groups were observed.
Cartilage quality: Knees injected with MIA had lost GAG and developed
structural damage (P< 0.001 for both compared to control knees). Median
GAG loss and structural damage was less in the group treated with rat
MSCs than in the saline treated group, albeit no signiﬁcant differences
were found between any of the treatment groups.
Conclusions: The treatment with injection of rat MSCs caused a signiﬁcant
increase in weight distributed to the affected limb, indicating a reduction
of joint discomfort. This is the ﬁrst study that evaluates the effect of cell
therapy on pain in a small animal OAmodel. In addition, the injection of rat
MSCs caused a trend towards reduction of cartilage and subchondral bone
changes, albeit no signiﬁcant differences were observed between any of
the treatment groups. The absence of statistically signiﬁcant effects of the
treatments on cartilage and bone structure might be related to several
factors, including the time of injection, the OA model or the number of
injected cells. To improve treatment effect, cell number, cell type and the
time point of treatment should be further optimized.
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CARTILAGE- AND SUBCHONDRAL BONE DERIVED FACTORS REGULATE
COLLAGEN PRODUCTION IN MSC
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Purpose: Functional repair of critical size articular cartilage defects is still
a considerable challenge in the ﬁeld of tissue regeneration. To effectively
improve the quality and durability of tissue-engineered neocartilage
a better understanding of microenvironmental cues provided from
surrounding cartilage and subchondral bone tissue and the modulating
inﬂuence of neighbouring cells and tissue interfaces in vivo on chondro-
genic differentiation of MSC are essential.
This study is designed to identify microenvironmental conditions which
promote, prevent or interfere with chondrogenic differentiation of
mesenchymal stem cells (MSC) and to analyse their impact on hyaline
cartilage like quality and biomechanical properties of regenerated tissue.
